Henry Schein, Inc. HSIC
86.37
0.84
0.98%
as of 25 Sep
- Market cap
- $9.5B
- P/E
- 25.0×
Follow HSIC
Indexes
indicate stock being part of an index,
Insider Buys
alert about insiders buying in the last 12 month
Henry Schein, Inc. (HSIC) Return on equity
Henry Schein, Inc.'s return on equity over the twelve months to 30 June 2026 was 10.2%, up 0.2 percentage points from fiscal 2025 (10.0%). Over the past ten years it has ranged from 9.38% (fiscal 2024) to 19.4% (fiscal 2019); the current reading is higher than 27% of that period. That is above the Medical Distribution industry median of 0.00% and above the Healthcare sector median of −32.0%.
Return on equity, annual
Annual
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | 10.0% | 0.66 |
| FY2024 | 9.38% | (0.54) |
| FY2023 | 9.92% | (3.27) |
| FY2022 | 13.2% | (2.49) |
| FY2021 | 15.7% | 5.07 |
| FY2020 | 10.6% | (8.76) |
| FY2019 | 19.4% | 2.53 |
| FY2018 | 16.8% | 2.39 |
| FY2017 | 14.5% | (3.37) |
| FY2016 | 17.8% | 1.02 |
Against its own ten years
Low 9.38%
High 19.4%
Ten-year median
14.5%
Current reading's percentile
27
Return on equity against peers
| Company | Return on equity |
|---|---|
| COR Cencora, Inc. compare | 96.3% |
| ACH Accendra Health, Inc. compare | 72.6% |
| YI 111, Inc. Sponsored ADR compare | 12.3% |
| HSIC Henry Schein, Inc. | 10.2% |
| AHG Akso Health Group Sponsored ADR compare | 0.00% |
| CAH Cardinal Health, Inc. compare | −64.0% |
| COSM Cosmos Health Inc. compare | −104.0% |
| FOCL FocalTherics compare | −133.5% |
| MCK McKesson Corporation compare | −168.5% |
| Medical Distribution industry median | 0.00% |
| Healthcare sector median | −32.0% |
| Market median | 1.76% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on HSIC
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement